United States · FDA National Drug Code directory
Irbesartan
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 33342-048_5a240405-5eb7-46ca-811b-d8dd93ee43d3
- Product NDC
- 33342-048
- Form
- TABLET
- Composition / generic term
- Irbesartan
- Labeler
- Macleods Pharmaceuticals Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20120927
- Source listing expiry
- 20271231
Source-listed ingredients
- IRBESARTAN — 150 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (33342-048-07) · 33342-048-07
- 90 TABLET in 1 BOTTLE (33342-048-10) · 33342-048-10
- 10 BLISTER PACK in 1 CARTON (33342-048-12) / 10 TABLET in 1 BLISTER PACK · 33342-048-12
- 500 TABLET in 1 BOTTLE (33342-048-15) · 33342-048-15
- 6800 TABLET in 1 POUCH (33342-048-65) · 33342-048-65
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →